AbbVie has agreed to buy Apogee Therapeutics for about $10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation...
Jay BilasJun 22, 2026, 07:00 AM ETClose College basketball analyst for ESPN and ESPN Insider
Played and coached at Duke
Practicing attorneyMultiple AuthorsThe 2026...